Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: Fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3559-3565

  Yanagita, Manabu ^a,b   Hiroi, Takachika ^a   Kitagaki, Noriko ^a   Hamada, Shigeyuki ^b   Hiro o, Ito ^c   Shimauchi, Hidetoshi ^b   Murakami, Shinya ^b   Okada, Hiroshi ^b   Kiyono, Hiroshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; CYTOKINE; EXOTOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIGEN SPECIFICITY; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; FIMBRIA; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBMANDIBULAR GLAND; VACCINATION; VIBRIO CHOLERAE;

ANIMALS; B-LYMPHOCYTES; BACTERIAL ADHESION; CHOLERA TOXIN; CYTOKINES; EPITHELIAL CELLS; FEMALE; FIMBRIAE, BACTERIAL; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; INFLAMMATION; KB CELLS; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; MOUTH MUCOSA; NASAL MUCOSA; NASOPHARYNX; RETICULOENDOTHELIAL SYSTEM; SUBMANDIBULAR GLAND; TH1 CELLS; TH2 CELLS;

EID: 0033559141     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Mestecky, J., and J. R. McGhee. 1989. New strategies for oral immunization. Curr. Top. Microbiol. Immunol. 146:1.
2. McGhee, J. R., J. Mestecky, M. F. Dertzbaugh, J. H. Eldridge, M. Hirasawa, and H. Kiyono. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10:75.
3. Ogra, P. L. 1996. Mucosal immunoprophylaxis: an introductory overview. In Mucosal Vaccine. H. Kiyono, P. L. Ogra, and J. R. McGhee, eds. Academic Press, San Diego, CA, p. 3.
4. Xu-Amano, J., H. Kiyono, R. J. Jackson, H. F. Staats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai, and J. R. McGhee. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid by use of cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1309.
5. Xu-Amano, J., R. J. Jackson, K. Fujihashi, H. Kiyono, H. F. Staats, and J. R. McGhee. 1994. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 12:903.
6. Cong, Y., C. T. Weaver, and C. O. Elson. 1997. The mocosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression. J. Immunol. 159:5301.
7. MacDermott, R. P., and W. F. Stenson. 1988. Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease. Adv. Immunol. 42:285.
8. Mayrand, D., and S. C. Holt. 1988. Biology of asaccharolytic black-pigmented Bacteroides species. Microbiol. Rev. 52:134.
9. Paye, R. C., and R. Genco. 1996. Mucosal immunity and periodontitis. In Mucosal Vaccine. H. Kiyono, P. L. Ogra, and J. R. McGhee, eds. Academic Press, San Diego, CA, p. 437.
10. Okada, H., T. Kida, and H. Yamagami. 1983. Identification and distribution of immunocompetent cells in inflamed gingiva of human chronic periodontitis. Infect. Immun. 41:365.
11. Cutler, C. W., J. R. Kalmar, and C. A. Genco. 1995. Pathologic strategies of the oral anaerobe, Parphyromonas gingivalis. Trends Microbiol. 3:45.
12. Ogawa, T., Y. Kusumoto, H. Kiyono, J. R. McGhee, and S. Hamada. 1992. Occurrence of antigen-specific B cells following oral or parenteral immunization with Porphyromonas gingivalis fimbriae. Int. Immunol. 4:1003.
13. Ogawa, T., H. Shimauchi, and S. Hamada. 1989. Mucosal and systemic immune responses in BALB/c mice to Bacteroides gingvalis fimbriae administered orally. Infect. Immun. 57:3466.
14. Yamamoto, S., H. Kiyono, M. Yamamoto, K. Imaoka, M. Yamamoto, K. Fujihashi, F. W. Van Ginkel, M. Noda, Y. Takeda, and J. R. McGhee. 1997. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA 94:5267.
15. Hiroi, T., K. Iwatani, H. Iijima, S. Kodama, M. Yanagita, and H. Kiyono. 1998. Nasal immune system: distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively. Eur. J. Immunol. 28:3346.
16. Asanuma, H., Y. Inaba, C. Aizawa, T. Kurata, and S. Tamura. 1995. Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase. J. Immunol. Methods 187:41.
17. Mega, J., J. R. McGhee, and H. Kiyono. 1992. Cytokine- and Ig-producing cells in mucosal effector tissues: analysis of IL-5- and IFN-γ-producing T cells, T cells receptor expression, and IgA plasma cells from mouse salivary gland-associated tissues. J. Immunol. 148:2030.
18. Jackson, R. J., K. Fujihashi, J. Xu-Amano, H. Kiyono, C. O. Elson, and J. R. McGhee. 1993. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun. 61:4272.
19. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
20. Reiner, S. L., S. Zheng, D. B. Corry, and R. M. Locksley. 1994. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods 175:275.
21. Hiroi, T., K. Fujihashi, J. R. McGhee, and H. Kiyono. 1995. Polarized Th2 cytokine expression by both mucosal γδ and αβ T cells. Eur. J. Immunol. 25:2743.
22. Mintz, K. P., and P. M. Five-Taylor. 1994. Adhesion of Actinobacillus actinomycetemcomitans to a human oral cell line. Infect. Immun. 62:3672.
23. Rudin, A., E.-L. Johansson, C. Bergquist, and J. Holmgren. 1998. Differential kinetics and distribution of antibodies in serum and nasal and vaginal serections after nasal and oral vaccination of humans. Infect. Immun. 66:3390.
24. Tamura, S.-I., A. Yamanaka, M. Shimohara, T. Tomita, K. Komase, Y. Tsuda, Y. Suzuki, T. Nagamine, K. Kawahara, H. Danhara, C. Aizawa, A. Oya, and T. Kurata. 1994. Synergistic action of cholera toxin B subunit (and E. coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 12:419.
25. Yamamoto, M., D. E. Briles, S. Yamamoto, M. Ohmura, H. Kiyono, and J. R. McGhee. 1998. A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A. J. Immunol. 161:4115.
26. Munoz, E., A. M. Zubiaga, M. Merrow, N. P. Sauter, and B. T. Huber. 1990. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 172:95.
27. Marinaro, M., H. F. Staats, T. Hiroi, R. J. Jackson, M. Coste, P. N. Boyaka, N. Okahashi, M. Yamamoto, H. Kiyono, H. Bluethmann, K. Fujihashi, and J. R. McGhee. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper (Th2) cells and IL-4. J. Immunol. 155:4621.
28. McIntyre, T. M., M. R. Kehry, and C. M. Snapper. 1995. Novel in vitro model for high-rate IgA class-switching. J. Immunol. 154:3136.
29. Beagley, K. W., J. H. Eldridge, H. Kiyono, M. P. Everson, W. J. Koopman, T. Honjo, and J. R. McGhee. 1988. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. J. Immunol. 141:2035.
30. Beagley, K. W., J. H. Eldridge, F. Lee, H. Kiyono, M. P. Everson, W. J. Koopman, T. Hirano, T. Kishimoto, and J. R. McGhee. 1989. Interleukins and IgA synthesis: human and murine IL-6 induce high rate IgA secretion in IgA-committed cells. J. Exp. Med. 169:2133.
31. Briere, F., J. M. Bridon, D. Chevet, G. Souillet, F. Bienvenu, C. Guret, H. Martines-Valdez, and J. Banchereau. 1994. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J. Clin. Invest. 94:97.
32. Mestecky, J. and J. R. McGhee. 1987. Immunogloblin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:153.
33. Coffman, R. L., D. A. Lebman, and B. Schrader. 1989. Transforming growth factor-β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 170:1039.
34. Lamont, R. J., A. Chan, C. M. Belton, K. T. Izutsu, D. Vasel, and A. Weinberg. 1995. Porphyromonas gingivalis invasion of gingival epithelial cells. Infect. Immun. 63:3878.
35. Duncan, M. J., S. Nakao, Z. Skobe, and H. Xie. 1993 Interaction of Porphyromonas gingivalis with epithelial cells. Infect. Immun. 61:2260.
36. Njoroge, T., R. J. Genco, H. T. Sojar, N. Hamada, and C. A. Genco. 1997. A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect. Immun. 65:1980.
37. Isogai, H., H. Isogai, F. Yoshimura, T. Suzuki, W. Kagota, and K. Takano. 1988. Specific inhibition of adherence of an oral strain of Bacteroides gingivalis 381 to epithelial cells by monoclonal antibodies against the bacterial funbriae. Arch. Oral Biol. 7:479.
38. Du, L., P. Pellen-Mussi, F. Chandad, C. Mouton, and M. Bonnaure-Mallet. 1997. Fimbriae and the hemagglutinating adhesin HA-Ag2 mediate adhesion of Porphyromonas gingivalis to epithelial cells. Infect. Immun. 65:3875.
39. Hirano, T., S. Akira, T. Taga, and T. Kishimoto. 1990. Biological and clinical aspects of interleukin 6. Immunol. Today 11:443.
40. Baggiolini, M., B. Dewald, and B. Moser 1994. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv. Immunol. 55:97.
41. Ebnet, K., E. Kaldjian, A. O. Anderson, and S. Shaw. 1996. Orchestrated information transfer underlying leukocyte endothelial interactions. Annu. Rev. Immunol. 14:155.
42. Jung, H. C., L. Eckmann, S.-k. Yang, A. Panja, J. Fiere, F. Morzycka-Wroblewska, and M. F. Kagnoff. 1995. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95:55.